data_1ewi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ewi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.279 0.562 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 2' ' ' VAL . 6.4 p -179.23 84.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.464 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 4' ' ' GLN . . . -115.69 -112.48 2.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' SER . 16.8 tt0 45.16 26.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 9' ' ' ALA . 40.4 tp -37.04 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.643 -0.661 . . . . 0.0 110.388 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' GLN . 13.5 t -122.74 -29.13 4.06 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.049 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.21 51.07 2.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 12' ' ' ALA . . . 166.96 -27.42 0.16 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' O ' ' CG1' ' A' ' 13' ' ' ILE . . . -67.98 -65.2 0.72 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.497 -1.002 . . . . 0.0 109.671 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.532 ' CA ' HG13 ' A' ' 13' ' ' ILE . 3.7 tp -45.72 -53.09 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.636 . . . . 0.0 110.488 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 15' ' ' GLN . . . -66.96 -26.59 66.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 108.812 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 8' ' ' GLY . . . -80.21 -12.02 59.68 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.568 -0.707 . . . . 0.0 109.503 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.561 ' CG1' ' O ' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -87.57 -47.51 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.0 108.777 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 mtp -84.62 -22.99 29.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 tt0 -90.11 -39.54 12.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 12' ' ' ALA . 27.8 tptt -69.97 -3.25 15.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 109.037 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.83 8.41 85.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.462 ' OD1' ' HE2' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 67.92 48.99 0.94 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -87.93 58.31 4.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.461 ' HB3' ' O ' ' A' ' 19' ' ' THR . 13.6 t-20 66.54 51.04 1.17 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.289 -0.882 . . . . 0.0 109.035 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 21' ' ' ILE . 27.2 mt -148.66 63.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 15.2 ttmm -141.69 59.68 10.22 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.289 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.566 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 37.7 Cg_endo -82.71 48.44 2.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.467 2.112 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 HD12 ' CB ' ' A' ' 9' ' ' ALA . 1.7 mt -150.12 30.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 46' ' ' MET . 0.2 OUTLIER -89.88 80.58 6.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.135 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.06 160.43 15.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.457 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 71' ' ' LEU . 5.4 m -89.99 113.71 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.397 -0.815 . . . . 0.0 109.524 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.34 -20.0 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' CB ' ' HB3' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -149.99 173.48 13.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.696 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.477 HG13 ' CD1' ' A' ' 44' ' ' LEU . 2.5 tt -147.06 153.93 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -144.51 91.65 6.2 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.563 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.19 129.56 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.664 2.243 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' HB ' ' CB ' ' A' ' 41' ' ' ARG . 3.4 mp -109.73 72.49 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' A' ' 34' ' ' THR . 0.5 OUTLIER -127.41 22.07 6.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -71.26 163.57 27.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 37' ' ' ASN . . . -68.05 153.01 52.84 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.434 ' O ' ' OG ' ' A' ' 38' ' ' SER . 11.3 t-20 66.26 43.01 2.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -1.188 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 37' ' ' ASN . 7.3 m -166.66 154.52 9.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.424 ' O ' HG23 ' A' ' 33' ' ' ILE . 35.8 Cg_endo -78.11 164.03 27.46 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.592 2.195 . . . . 0.0 110.451 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.04 109.18 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.598 2.199 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 5.8 mtm180 -132.98 163.66 28.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' OH ' ' OE2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -140.49 77.04 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -90.16 121.21 32.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' HG11 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -110.1 163.61 13.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -108.12 112.12 24.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.521 ' CE ' HG13 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -105.2 147.38 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 29.8 t -149.96 173.55 13.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 0.0 109.746 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 35.3 m-20 -122.06 -10.91 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.472 -0.768 . . . . 0.0 109.403 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.16 28.65 1.47 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.88 -59.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -1.146 . . . . 0.0 109.057 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.423 ' HB2' HD11 ' A' ' 10' ' ' ILE . 9.3 m120 -110.24 118.7 37.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -99.04 172.15 7.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.562 HD22 ' CE1' ' A' ' 56' ' ' PHE . 0.4 OUTLIER -138.4 -71.03 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 45' ' ' LEU . 5.1 t 71.68 41.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.417 ' OG ' HG23 ' A' ' 94' ' ' VAL . 1.4 t -122.35 -15.88 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.619 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -106.18 92.39 4.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.524 ' HA ' ' CE ' ' A' ' 57' ' ' MET . 6.0 tpt -150.06 65.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.2 OUTLIER -149.97 55.62 0.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.395 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' LEU . . . -113.07 -135.14 0.35 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 17.2 6.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.918 -1.113 . . . . 0.0 108.613 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 2.6 mp0 -65.0 -9.24 20.15 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.542 -0.724 . . . . 0.0 109.782 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' ASN . 3.1 mm? -69.35 -13.17 62.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' CB ' ' CG1' ' A' ' 66' ' ' VAL . 1.3 m-20 -48.7 177.32 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.77 . . . . 0.0 109.498 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 63' ' ' ASN . 35.6 Cg_endo -78.6 -67.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.646 2.23 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pp -90.14 10.12 25.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 109.646 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' CG1' ' CB ' ' A' ' 63' ' ' ASN . 9.8 p -79.14 1.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HA ' ' HG2' ' A' ' 70' ' ' GLN . 11.2 mt-10 -90.4 -34.31 15.7 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' SER . 2.9 tp10 -79.19 -29.4 42.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.396 -1.729 . . . . 0.0 108.04 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.03 -33.78 16.2 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.084 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.538 ' HG3' ' CD2' ' A' ' 71' ' ' LEU . 10.7 pt20 -75.53 -4.32 39.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.541 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 1.0 OUTLIER 179.29 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.384 -0.822 . . . . 0.0 108.934 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -61.05 -47.28 87.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.8 . . . . 0.0 109.74 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -162.24 47.83 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.212 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' SER . 6.6 t-20 83.09 64.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.338 0.589 . . . . 0.0 109.856 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.45 ' SG ' HG22 ' A' ' 27' ' ' VAL . 11.6 p -92.59 129.59 38.48 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.329 -0.857 . . . . 0.0 108.845 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.3 p -91.67 138.52 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.701 ' HA ' ' CG1' ' A' ' 101' ' ' VAL . 1.5 p -150.28 150.48 31.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.551 ' N ' ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -102.34 92.98 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.752 -1.217 . . . . 0.0 108.281 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG23 HD12 ' A' ' 79' ' ' ILE . 52.6 mt -48.49 142.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -35.45 9.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' HB3' ' CG ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.63 170.42 16.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.598 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.7 p90 178.6 142.56 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 83' ' ' ILE . 12.8 mt -88.13 93.49 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' HA ' ' CG1' ' A' ' 94' ' ' VAL . 44.5 t -90.01 111.27 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.01 120.09 7.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 108.71 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 1.6 m -89.6 151.03 22.13 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.139 -0.976 . . . . 0.0 110.122 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 2.9 mm? -102.48 95.75 6.46 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 6.4 ttmt 74.93 16.28 2.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.54 ' HB3' ' O ' ' A' ' 88' ' ' LYS . 17.8 t70 68.12 7.17 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.03 -63.42 0.31 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.47 66.41 9.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.579 -0.953 . . . . 0.0 108.698 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -43.36 156.99 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 109.964 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 56.0 t -150.09 91.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.532 ' HB ' ' CA ' ' A' ' 56' ' ' PHE . 1.1 t -110.16 151.52 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.103 -0.998 . . . . 0.0 109.594 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 58' ' ' LEU . 2.6 mt -125.83 149.08 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' A' ' 79' ' ' ILE . 2.3 tt -89.94 144.27 26.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.298 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.52 ' CG ' ' HB3' ' A' ' 81' ' ' ARG . 0.7 OUTLIER -106.71 -64.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.104 -0.997 . . . . 0.0 109.581 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 1.7 tt0 -146.32 -163.78 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -138.31 159.67 41.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.164 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.4 OUTLIER -154.31 76.88 1.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.967 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.701 ' CG1' ' HA ' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -179.83 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.628 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -36.87 -29.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.195 1.361 . . . . 0.0 107.867 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER 50.9 21.47 0.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 103' ' ' LYS . 1.2 m 164.99 43.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.212 1.006 . . . . 0.0 108.51 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.465 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . . . -82.68 44.42 0.9 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.423 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 73' ' ' SER . 64.9 tt0 -48.92 -30.09 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 106' ' ' GLU . . . 72.61 3.28 4.64 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -126.56 -33.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . . . -69.46 -99.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' GLY . 38.2 t 44.36 85.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.2 116.68 17.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.5 tp -121.3 145.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.8 154.51 6.59 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.166 . . . . 0.0 109.471 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.279 0.562 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 p -179.23 84.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.464 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 4' ' ' GLN . . . -115.69 -112.48 2.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' SER . 16.8 tt0 45.16 26.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 40.4 tp -37.04 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.643 -0.661 . . . . 0.0 110.388 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' GLN . 13.5 t -122.74 -29.13 4.06 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.049 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.21 51.07 2.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 12' ' ' ALA . . . 166.96 -27.42 0.16 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.897 ' CB ' HD11 ' A' ' 24' ' ' ILE . . . -67.98 -65.2 0.72 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.497 -1.002 . . . . 0.0 109.671 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 51' ' ' ASN . 3.7 tp -45.72 -53.09 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.636 . . . . 0.0 110.488 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -66.96 -26.59 66.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 108.812 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 8' ' ' GLY . . . -80.21 -12.02 59.68 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.568 -0.707 . . . . 0.0 109.503 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.956 HG21 ' HG3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -87.57 -47.51 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.0 108.777 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 mtp -84.62 -22.99 29.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 tt0 -90.11 -39.54 12.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HG2' HD12 ' A' ' 21' ' ' ILE . 27.8 tptt -69.97 -3.25 15.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 109.037 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.83 8.41 85.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.769 ' OD1' HG22 ' A' ' 13' ' ' ILE . 0.5 OUTLIER 67.92 48.99 0.94 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -87.93 58.31 4.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 19' ' ' THR . 13.6 t-20 66.54 51.04 1.17 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.289 -0.882 . . . . 0.0 109.035 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.716 HD12 ' HG2' ' A' ' 16' ' ' LYS . 27.2 mt -148.66 63.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG3' HG21 ' A' ' 13' ' ' ILE . 15.2 ttmm -141.69 59.68 10.22 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.289 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 37.7 Cg_endo -82.71 48.44 2.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.467 2.112 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.897 HD11 ' CB ' ' A' ' 9' ' ' ALA . 1.7 mt -150.12 30.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.893 HD23 ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -89.88 80.58 6.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.135 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.06 160.43 15.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.457 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.01 HG21 ' HA ' ' A' ' 71' ' ' LEU . 5.4 m -89.99 113.71 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.397 -0.815 . . . . 0.0 109.524 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.34 -20.0 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' CB ' ' HB3' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -149.99 173.48 13.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.696 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.767 HG13 HD12 ' A' ' 44' ' ' LEU . 2.5 tt -147.06 153.93 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -144.51 91.65 6.2 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.563 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.19 129.56 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.664 2.243 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB3' ' A' ' 41' ' ' ARG . 3.4 mp -109.73 72.49 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 34' ' ' THR . 0.5 OUTLIER -127.41 22.07 6.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -71.26 163.57 27.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' ASN . . . -68.05 153.01 52.84 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 11.3 t-20 66.26 43.01 2.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -1.188 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 m -166.66 154.52 9.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 33' ' ' ILE . 35.8 Cg_endo -78.11 164.03 27.46 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.592 2.195 . . . . 0.0 110.451 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.04 109.18 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.598 2.199 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.868 ' HB3' HD13 ' A' ' 33' ' ' ILE . 5.8 mtm180 -132.98 163.66 28.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 77.04 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -90.16 121.21 32.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.017 HD11 HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -110.1 163.61 13.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD12 ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -108.12 112.12 24.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.537 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -105.2 147.38 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 29.8 t -149.96 173.55 13.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 0.0 109.746 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 35.3 m-20 -122.06 -10.91 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.472 -0.768 . . . . 0.0 109.403 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.16 28.65 1.47 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.88 -59.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -1.146 . . . . 0.0 109.057 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.684 ' HB2' HD11 ' A' ' 10' ' ' ILE . 9.3 m120 -110.24 118.7 37.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -99.04 172.15 7.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -138.4 -71.03 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 45' ' ' LEU . 5.1 t 71.68 41.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG21 ' A' ' 94' ' ' VAL . 1.4 t -122.35 -15.88 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CZ ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.18 92.39 4.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.616 ' HE3' ' HA ' ' A' ' 57' ' ' MET . 6.0 tpt -150.06 65.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -149.97 55.62 0.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.395 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 96' ' ' LEU . . . -113.07 -135.14 0.35 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 17.2 6.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.918 -1.113 . . . . 0.0 108.613 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.629 ' HG2' ' NE2' ' A' ' 70' ' ' GLN . 2.6 mp0 -65.0 -9.24 20.15 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.542 -0.724 . . . . 0.0 109.782 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' ASN . 3.1 mm? -69.35 -13.17 62.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' CB ' ' CG1' ' A' ' 66' ' ' VAL . 1.3 m-20 -48.7 177.32 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.77 . . . . 0.0 109.498 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 63' ' ' ASN . 35.6 Cg_endo -78.6 -67.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.646 2.23 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pp -90.14 10.12 25.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 109.646 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' CG1' ' CB ' ' A' ' 63' ' ' ASN . 9.8 p -79.14 1.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 11.2 mt-10 -90.4 -34.31 15.7 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' SER . 2.9 tp10 -79.19 -29.4 42.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.396 -1.729 . . . . 0.0 108.04 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.03 -33.78 16.2 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.084 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 1.012 ' HG3' HD23 ' A' ' 71' ' ' LEU . 19.1 pt20 -75.53 -4.32 39.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.017 HD22 HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER 179.29 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.384 -0.822 . . . . 0.0 108.934 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -61.05 -47.28 87.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.8 . . . . 0.0 109.74 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -162.24 47.83 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.212 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' SER . 6.6 t-20 83.09 64.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.338 0.589 . . . . 0.0 109.856 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 11.6 p -92.59 129.59 38.48 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.329 -0.857 . . . . 0.0 108.845 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.921 ' H ' ' HB3' ' A' ' 105' ' ' ALA . 7.3 p -91.67 138.52 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.919 ' HA ' HG12 ' A' ' 101' ' ' VAL . 1.5 p -150.28 150.48 31.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -102.34 92.98 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.752 -1.217 . . . . 0.0 108.281 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD13 ' HG ' ' A' ' 96' ' ' LEU . 52.6 mt -48.49 142.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -35.45 9.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.547 ' HB3' ' CG ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.63 170.42 16.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.598 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.659 ' HD1' HG23 ' A' ' 84' ' ' VAL . 1.7 p90 178.6 142.56 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.702 HD12 HD13 ' A' ' 95' ' ' ILE . 12.8 mt -88.13 93.49 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.054 ' HA ' HG13 ' A' ' 94' ' ' VAL . 44.5 t -90.01 111.27 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.01 120.09 7.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 108.71 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 92' ' ' ARG . 1.6 m -89.6 151.03 22.13 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.139 -0.976 . . . . 0.0 110.122 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.641 HD23 HG23 ' A' ' 93' ' ' VAL . 2.9 mm? -102.48 95.75 6.46 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 6.4 ttmt 74.93 16.28 2.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 88' ' ' LYS . 17.8 t70 68.12 7.17 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.03 -63.42 0.31 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.47 66.41 9.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.579 -0.953 . . . . 0.0 108.698 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HA ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -43.36 156.99 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 109.964 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.641 HG23 HD23 ' A' ' 87' ' ' LEU . 56.0 t -150.09 91.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.054 HG13 ' HA ' ' A' ' 84' ' ' VAL . 1.1 t -110.16 151.52 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.103 -0.998 . . . . 0.0 109.594 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 58' ' ' LEU . 2.6 mt -125.83 149.08 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.823 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 2.3 tt -89.94 144.27 26.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.298 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.694 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -106.71 -64.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.104 -0.997 . . . . 0.0 109.581 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 1.7 tt0 -146.32 -163.78 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -138.31 159.67 41.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.164 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.4 OUTLIER -154.31 76.88 1.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.967 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.919 HG12 ' HA ' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -179.83 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.87 ' H ' HG13 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -36.87 -29.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.195 1.361 . . . . 0.0 107.867 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER 50.9 21.47 0.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 103' ' ' LYS . 1.2 m 164.99 43.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.212 1.006 . . . . 0.0 108.51 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.921 ' HB3' ' H ' ' A' ' 76' ' ' VAL . . . -82.68 44.42 0.9 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.423 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.62 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 64.9 tt0 -48.92 -30.09 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 106' ' ' GLU . . . 72.61 3.28 4.64 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -126.56 -33.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . . . -69.46 -99.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' GLY . 38.2 t 44.36 85.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.2 116.68 17.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.5 tp -121.3 145.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.8 154.51 6.59 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.166 . . . . 0.0 109.471 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.279 0.562 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.646 ' O ' HG13 ' A' ' 2' ' ' VAL . 6.4 p -179.23 84.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.464 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 4' ' ' GLN . . . -115.69 -112.48 2.82 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 6' ' ' SER . 16.8 tt0 45.16 26.16 0.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 40.4 tp -37.04 93.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.643 -0.661 . . . . 0.0 110.388 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 4' ' ' GLN . 13.5 t -122.74 -29.13 4.06 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.39 -0.819 . . . . 0.0 109.049 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -88.21 51.07 2.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 12' ' ' ALA . . . 166.96 -27.42 0.16 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.897 ' CB ' HD11 ' A' ' 24' ' ' ILE . . . -67.98 -65.2 0.72 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.497 -1.002 . . . . 0.0 109.671 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 51' ' ' ASN . 3.7 tp -45.72 -53.09 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.683 -0.636 . . . . 0.0 110.488 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' N ' HG23 ' A' ' 10' ' ' ILE . . . -66.96 -26.59 66.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 108.812 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 8' ' ' GLY . . . -80.21 -12.02 59.68 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.568 -0.707 . . . . 0.0 109.503 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.956 HG21 ' HG3' ' A' ' 22' ' ' LYS . 0.5 OUTLIER -87.57 -47.51 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.0 108.777 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.2 mtp -84.62 -22.99 29.75 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.397 -0.815 . . . . 0.0 109.526 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' CB ' ' O ' ' A' ' 11' ' ' ALA . 1.5 tt0 -90.11 -39.54 12.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.992 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.716 ' HG2' HD12 ' A' ' 21' ' ' ILE . 27.8 tptt -69.97 -3.25 15.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.026 -1.046 . . . . 0.0 109.037 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.83 8.41 85.94 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.769 ' OD1' HG22 ' A' ' 13' ' ' ILE . 0.5 OUTLIER 67.92 48.99 0.94 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' ASN . 0.3 OUTLIER -87.93 58.31 4.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' ' 19' ' ' THR . 13.6 t-20 66.54 51.04 1.17 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.289 -0.882 . . . . 0.0 109.035 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.716 HD12 ' HG2' ' A' ' 16' ' ' LYS . 27.2 mt -148.66 63.16 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.956 ' HG3' HG21 ' A' ' 13' ' ' ILE . 15.2 ttmm -141.69 59.68 10.22 Favored Pre-proline 0 C--N 1.299 -1.601 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.289 -178.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 22' ' ' LYS . 37.7 Cg_endo -82.71 48.44 2.77 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.467 2.112 . . . . 0.0 109.874 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.897 HD11 ' CB ' ' A' ' 9' ' ' ALA . 1.7 mt -150.12 30.08 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.893 HD23 ' HD3' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -89.88 80.58 6.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.111 -0.993 . . . . 0.0 109.135 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -106.06 160.43 15.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.355 -0.841 . . . . 0.0 109.457 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.01 HG21 ' HA ' ' A' ' 71' ' ' LEU . 5.4 m -89.99 113.71 26.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.397 -0.815 . . . . 0.0 109.524 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.2 tp -106.34 -20.0 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' CB ' ' HB3' ' A' ' 45' ' ' LEU . 1.0 OUTLIER -149.99 173.48 13.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.169 -0.957 . . . . 0.0 109.696 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.767 HG13 HD12 ' A' ' 44' ' ' LEU . 2.5 tt -147.06 153.93 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 109.379 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -144.51 91.65 6.2 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.563 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.19 129.56 9.68 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.664 2.243 . . . . 0.0 110.401 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.868 HD13 ' HB3' ' A' ' 41' ' ' ARG . 3.4 mp -109.73 72.49 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 0.0 109.487 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.402 ' O ' ' OG1' ' A' ' 34' ' ' THR . 0.5 OUTLIER -127.41 22.07 6.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.939 . . . . 0.0 109.474 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.9 p -71.26 163.57 27.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.242 -0.911 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' ASN . . . -68.05 153.01 52.84 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 36' ' ' GLY . 11.3 t-20 66.26 43.01 2.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.181 -1.188 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.3 m -166.66 154.52 9.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.505 ' O ' HG22 ' A' ' 33' ' ' ILE . 35.8 Cg_endo -78.11 164.03 27.46 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.592 2.195 . . . . 0.0 110.451 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.04 109.18 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.598 2.199 . . . . 0.0 110.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.868 ' HB3' HD13 ' A' ' 33' ' ' ILE . 5.8 mtm180 -132.98 163.66 28.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 77.04 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -90.16 121.21 32.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.905 . . . . 0.0 109.447 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.017 HD11 HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -110.1 163.61 13.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.546 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD12 ' OG ' ' A' ' 54' ' ' SER . 0.6 OUTLIER -108.12 112.12 24.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.537 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -105.2 147.38 28.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.316 -0.865 . . . . 0.0 109.272 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 29.8 t -149.96 173.55 13.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.158 -0.964 . . . . 0.0 109.746 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 35.3 m-20 -122.06 -10.91 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.472 -0.768 . . . . 0.0 109.403 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.16 28.65 1.47 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.88 -59.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -1.146 . . . . 0.0 109.057 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.684 ' HB2' HD11 ' A' ' 10' ' ' ILE . 9.3 m120 -110.24 118.7 37.05 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.1 t -99.04 172.15 7.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.542 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -138.4 -71.03 0.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.472 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 45' ' ' LEU . 5.1 t 71.68 41.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.327 -0.858 . . . . 0.0 109.554 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' HB3' HG21 ' A' ' 94' ' ' VAL . 1.4 t -122.35 -15.88 7.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.657 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.723 ' CZ ' HD22 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.18 92.39 4.12 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 109.709 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.616 ' HE3' ' HA ' ' A' ' 57' ' ' MET . 6.0 tpt -150.06 65.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.331 -0.856 . . . . 0.0 109.955 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.773 ' O ' HG23 ' A' ' 95' ' ' ILE . 0.2 OUTLIER -149.97 55.62 0.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.395 179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.823 ' HB2' ' O ' ' A' ' 96' ' ' LEU . . . -113.07 -135.14 0.35 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.9 17.2 6.99 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.918 -1.113 . . . . 0.0 108.613 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG1' ' A' ' 66' ' ' VAL . 2.6 mp0 -65.0 -9.24 20.15 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.542 -0.724 . . . . 0.0 109.782 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 63' ' ' ASN . 3.1 mm? -69.35 -13.17 62.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.917 . . . . 0.0 109.099 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.548 ' CB ' ' CG1' ' A' ' 66' ' ' VAL . 1.3 m-20 -48.7 177.32 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.467 -0.77 . . . . 0.0 109.498 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 63' ' ' ASN . 35.6 Cg_endo -78.6 -67.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.646 2.23 . . . . 0.0 111.237 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pp -90.14 10.12 25.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.13 -0.981 . . . . 0.0 109.646 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.548 ' CG1' ' CB ' ' A' ' 63' ' ' ASN . 9.8 p -79.14 1.32 2.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 11.2 mt-10 -90.4 -34.31 15.7 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 72' ' ' SER . 2.9 tp10 -79.19 -29.4 42.88 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 113.396 -1.729 . . . . 0.0 108.04 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -90.03 -33.78 16.2 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.202 -0.599 . . . . 0.0 110.084 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 1.012 ' HG3' HD23 ' A' ' 71' ' ' LEU . 10.7 pt20 -75.53 -4.32 39.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.227 -0.92 . . . . 0.0 109.1 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.017 HD22 HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER 179.29 57.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.384 -0.822 . . . . 0.0 108.934 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' A' ' 68' ' ' GLU . 0.3 OUTLIER -61.05 -47.28 87.09 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.8 . . . . 0.0 109.74 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -162.24 47.83 0.17 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.212 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' SER . 6.6 t-20 83.09 64.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.338 0.589 . . . . 0.0 109.856 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 11.6 p -92.59 129.59 38.48 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.329 -0.857 . . . . 0.0 108.845 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.921 ' H ' ' HB3' ' A' ' 105' ' ' ALA . 7.3 p -91.67 138.52 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.176 -0.953 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.919 ' HA ' HG12 ' A' ' 101' ' ' VAL . 1.5 p -150.28 150.48 31.56 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.575 ' N ' ' HB ' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -102.34 92.98 4.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.752 -1.217 . . . . 0.0 108.281 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.788 HD13 ' HG ' ' A' ' 96' ' ' LEU . 52.6 mt -48.49 142.62 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.205 -0.934 . . . . 0.0 109.527 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.38 -35.45 9.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.286 -0.884 . . . . 0.0 109.599 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.547 ' HB3' ' CG ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -138.63 170.42 16.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.974 . . . . 0.0 109.598 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.659 ' HD1' HG23 ' A' ' 84' ' ' VAL . 1.7 p90 178.6 142.56 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.246 -0.909 . . . . 0.0 109.456 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.702 HD12 HD13 ' A' ' 95' ' ' ILE . 12.8 mt -88.13 93.49 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.403 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.054 ' HA ' HG13 ' A' ' 94' ' ' VAL . 44.5 t -90.01 111.27 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 109.729 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.01 120.09 7.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 108.71 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.714 HG23 ' HA ' ' A' ' 92' ' ' ARG . 1.6 m -89.6 151.03 22.13 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.139 -0.976 . . . . 0.0 110.122 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.641 HD23 HG23 ' A' ' 93' ' ' VAL . 2.9 mm? -102.48 95.75 6.46 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.321 -0.862 . . . . 0.0 109.43 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 6.4 ttmt 74.93 16.28 2.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.439 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.544 ' HB3' ' O ' ' A' ' 88' ' ' LYS . 17.8 t70 68.12 7.17 5.68 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.411 0.624 . . . . 0.0 109.588 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.03 -63.42 0.31 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.47 66.41 9.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.579 -0.953 . . . . 0.0 108.698 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.714 ' HA ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -43.36 156.99 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.34 -0.85 . . . . 0.0 109.964 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.641 HG23 HD23 ' A' ' 87' ' ' LEU . 56.0 t -150.09 91.19 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.319 -0.863 . . . . 0.0 108.923 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.054 HG13 ' HA ' ' A' ' 84' ' ' VAL . 1.1 t -110.16 151.52 12.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.103 -0.998 . . . . 0.0 109.594 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 58' ' ' LEU . 2.6 mt -125.83 149.08 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.562 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.823 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 2.3 tt -89.94 144.27 26.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.944 . . . . 0.0 109.298 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.694 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -106.71 -64.56 1.16 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.104 -0.997 . . . . 0.0 109.581 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 1.7 tt0 -146.32 -163.78 1.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.907 . . . . 0.0 109.785 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.629 ' O ' HD12 ' A' ' 99' ' ' LEU . 0.5 OUTLIER -138.31 159.67 41.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.164 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 78' ' ' GLN . 0.4 OUTLIER -154.31 76.88 1.05 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.083 -1.011 . . . . 0.0 110.967 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.919 HG12 ' HA ' ' A' ' 77' ' ' CYS . 0.5 OUTLIER -179.83 -158.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 104.794 -2.299 . . . . 0.0 104.794 179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.87 ' H ' HG13 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -36.87 -29.41 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 120.195 1.361 . . . . 0.0 107.867 179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER 50.9 21.47 0.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 103' ' ' LYS . 1.2 m 164.99 43.26 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.212 1.006 . . . . 0.0 108.51 -178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.921 ' HB3' ' H ' ' A' ' 76' ' ' VAL . . . -82.68 44.42 0.9 Allowed 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.423 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.62 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 64.9 tt0 -48.92 -30.09 5.51 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.62 ' HB3' ' O ' ' A' ' 106' ' ' GLU . . . 72.61 3.28 4.64 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.613 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -126.56 -33.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 110' ' ' VAL . . . -69.46 -99.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 109' ' ' GLY . 38.2 t 44.36 85.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -1.157 . . . . 0.0 109.456 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.2 116.68 17.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.5 tp -121.3 145.93 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 137.8 154.51 6.59 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.217 -1.166 . . . . 0.0 109.471 -179.985 . . . . . . . . 0 0 . 1 stop_ save_